Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

610 ARTÍCULOS , VIENDO DEL 466 AL 480

Comparative Assessment of Mental and Cognitive Status

Gkousi O, Vlamos P.

Adv Exp Med Biol. 2026;1490:389-397. doi: 10.1007/978-3-032-03402-1_41.

Risk of Alzheimer Disease and Related Dementia after Retinal Vascular Occlusion: A Nationwide Cohort Analysis

Tsai HR, Lin YJ, Loh CH, Lee YC, Huang HK.

Ophthalmol Retina. 2026 Feb;10(2):117-127. doi: 10.1016/j.oret.2025.10.017. Epub 2026 Jan 1.

Genetic risk in Alzheimer's disease

Pan Y, Cho H, Lou Q, Zhang W, Asken B, Song Q.

NPJ Syst Biol Appl. 2026 Feb 14;12(1):39. doi: 10.1038/s41540-026-00665-8.

Lecanemab appropriate use recommendations for clinical practice in the UK

Mummery CJ, Rasmussen J, Blackburn D, Coulthard E, Davies RR, Dorsey R, Fox NC, Hosseini AA, Ivenso C, Jones M, Kennelly SP, Kipps C, Lashley D, Mackay G, Negi R, Nilforooshan R, Passmore PA, Perry R, Raymont V, Rowe JB, Russ TC, Taylor JP, Burns A.

J Neurol Neurosurg Psychiatry. 2026 Apr 15;97(5):372-384. doi: 10.1136/jnnp-2025-336597.

How does type 2 diabetes modify the risk of Alzheimer's disease?

Sutherland GT, Chen A, Nguyen-Hao HT, Mundell H, Aladyeva E, Hofer MJ, Harari O, Twigg SM.

Alzheimers Dement. 2026 May;22(5):e71471. doi: 10.1002/alz.71471.

[Alzheimer's disease and bilingualism]

Syromyatnikov NN, Preobrazhenskaya IS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(4. Vyp. 2):40-46. doi: 10.17116/jnevro202612604240.

Proton Pump Inhibitors and the Risk of Dementia

Andrade C.

J Clin Psychiatry. 2026 Apr 13;87(2):26f16420. doi: 10.4088/JCP.26f16420.

Cumulative blood pressure and risk of dementia and cognitive decline: a systematic review and meta-analysis

Wang R, Gao Y, Ee N, Akinyede F, Xu X, Chen L, Xiong S, Chen X, Anderson CS, Harris K, Peters R.

J Prev Alzheimers Dis. 2026 Apr;13(4):100500. doi: 10.1016/j.tjpad.2026.100500. Epub 2026 Feb 7.

Relationship between age and severity of cognitive impairment at diagnosis for early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNI

Hammers DB, Eloyan A, Thangarajah M, Taurone A, Gao S, Beckett L, Kirby K, Dage JL, Nudelman K, Aisen P, Reman R, Vemuri P, La Joie R, Touroutoglou A, Atri A, Clark D, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu JC, Mendez MF, Womack K, Musiek E, Onyike CU, Riddle M, Grant I, Rogalski E, Johnson ECB, Salloway S, Sha SJ, Turner RS, Wingo TS, Wolk DA, Carrillo MC, Dickerson BC, Rabinovici GD, Apostolova LG; LEADS Consortium; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2026 Feb;22(2):e71160. doi: 10.1002/alz.71160.

Infection, vaccination and risk of dementia: a proposed immunological model

Devine J, Jacobs B, Leroux-Roels I, Leroux-Roels G, van der Most R.

Front Immunol. 2026 Mar 4;17:1748535. doi: 10.3389/fimmu.2026.1748535. eCollection 2026.

The interventional effect of acupuncture on overall cognitive function in Alzheimer's disease spectrum disorders: A meta-analysis

Chen Y, Zhao S, Yang F, Wang Y, Han Z, Han F, Wang Z, Chen Z, Sun K, Liang P, Li K.

J Alzheimers Dis. 2026 Jun;111(3):959-978. doi: 10.1177/13872877261438495. Epub 2026 Apr 8.

Plasma Phosphorylated Tau 217 and Incident Mild Cognitive Impairment and Dementia in Older Women

Shadyab AH, Zhang B, LaCroix AZ, Mielke MM, Resnick SM, Nguyen S, Ferrucci L, Libermann TA, Ngo L, Casanova R, Reiner AP, Li D, Nievergelt CM, Maihofer AX, Manson JE, McEvoy LK.

JAMA Netw Open. 2026 Mar 2;9(3):e261295. doi: 10.1001/jamanetworkopen.2026.1295.

Alzheimer and cardiovascular genetic scores and cognition: the FINGER randomized controlled trial

Saadmaan G, Dalmasso MC, Maria M, Lehtisalo J, Hiltunen M, Kaikkonen MU, Levälahti E, Mangialasche F, Perola M, Ramirez A, Stephen R, Ngandu T, Kivipelto M, Solomon A.

Brain. 2026 Feb 7;149(2):644-652. doi: 10.1093/brain/awaf277.

Ginkgo biloba for cognitive impairment and dementia

Wieland LS, Ludeman E, Chi Y, Feinberg TM, Chen IH, Chen KH, Zhu Y, Wolverson E, Amri H.

Cochrane Database Syst Rev. 2026 Feb 5;2(2):CD013661. doi: 10.1002/14651858.CD013661.pub2.

Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical Trial

Devanand DP, Wisniewski T, Razlighi Q, Qian M, Wei R, Andrews HF, Acosta EP, Bell KL, Pelton GH, Deliyannides D, Perrin AC, Caccappolo E, Gershon AA, Prasad KM, Kreisl WC, Mintz A, Huey ED.

JAMA. 2026 Feb 10;335(6):511-522. doi: 10.1001/jama.2025.21738.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias